Karen Mangasarian: Patent Prosecutor of the Year at the Inaugural LSPN Awards
Please join Haley Guiliano (HG) in honoring Partner Karen Mangasarian for being named Patent Prosecutor of the Year at the inaugural Life Sciences Patent Network (LSPN) Awards USA on Tuesday, May 6, 2025, at The Colonnade Hotel in Boston, following the first day of the prestigious LSPN North America–Spring 2025 Conference. Singled out for distinction amongst industry-leading peers, Karen’s achievement highlights her leadership in navigating complex technical landscapes and exemplifies the high standards of precision, expertise, and excellence HG is known for.
Hosted by Life Sciences Intellectual Property Review, the LSPN Awards shine a spotlight on individuals and firms who are driving meaningful change and innovation in the life sciences. Nominated by their peers and judged by an independent panel of industry experts, the awards recognize the practitioners shaping landscape of life sciences intellectual property with brilliance, dedication, and strategic vision.
The judging panel remarked, “Karen is the rare life science patent prosecutor fluent in the language of biologics and small molecules; this remarkable technical talent, coupled with immense legal skills in both spaces and a knack for aligning patent and commercial strategies, make her a must-have patent prosecutor for any life science client seeking commercially vital patents for precision medicines or complex small molecules or both!”
HG extends our heartfelt congratulations to Karen on this exceptional award for work securing critical patents, championing innovation, and navigating complex IP challenges to advance client success. For more information about the LSPN Awards and to view the full list of winners, please visit the official website.
About Karen Mangasarian: Karen Mangasarian has more than 25 years of experience exceptional work in securing critical patents, championing innovation, and navigating complex IP challenges, advising U.S. and international biotechnology, pharmaceutical, and life sciences clients on global IP issues. She has drafted and prosecuted hundreds of patent applications globally, many of which cover therapeutics approved by regulatory agencies. Moreover, she has extensive experience in contentious patent matters, including interferences, re-examinations, oppositions, and litigation. She offers a full range of IP services, including rendering legal opinions on patent invalidity and non-infringement, conducting patent landscape and freedom-to-operate analyses, advising on patent term extensions, and IP due diligence investigations for various types of transactions.
